USPTO serial 98014161
HEPLISAV-B
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 9, 2024
- Examiner
- WICKERSHAM, JUSTIN SPENCER
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HEPLISAV-B?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dynavax Technologies Corporation
Emeryville, CA
Dynavax Technologies Corporation
Emeryville, CA
Dynavax Technologies Corporation
Emeryville, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Beth M. Goldman
BETH M. GOLDMAN ORRICK, HERRINGTON & SUTCLIFFE LLPIP PROSECUTION DEPARTMENT2050 MAIN STREET, SUITE 1100IRVINE, CA 92614-8255Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Providing medical and other health information to medical professionals in the fields of medicine, health, pharmaceuticals, vaccines, and vaccine adjuvants; Providing medical information, health information and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical, health and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via a website; Providing information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceuticals via a website; Providing patients with information in the fields of medicine, health and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals | ACTIVE | Feb 12, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dynavax Technologies Corporation
- Other trademarks owned by Dynavax Technologies Corporation
- Other trademarks owned by Dynavax Technologies Corporation
- Other trademarks in Class 044
- Similar marks named HEPLISAV-B
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 13, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 13, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 13, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 20, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 29, 2023 | NWAP | NEW APPLICATION ENTERED | — |